Companion Animal Welfare

Dog Immune-Mediated Hemolytic Anemia: A Welfare Emergency

Immune-mediated hemolytic anemia (IMHA) is a life-threatening condition where a dog's immune system destroys its own red blood cells, requiring urgent and intensive treatment.

Key Facts

Welfare Considerations

IMHA causes profound suffering in a short timeframe. Severe anemia means tissues are starved of oxygen, causing weakness, confusion, and the sensation of breathlessness even at rest. Dogs may deteriorate from apparent health to near-collapse within days. Hospitalization typically involves blood transfusions, multiple daily medications, IV fluid management, and repeated blood tests — a stressful, invasive experience for an already critically ill animal. The high mortality rate means many owners face difficult euthanasia decisions during acute crises. Surviving dogs require months of immunosuppressive therapy with associated side effects including susceptibility to infections. Relapse rates are significant, meaning many dogs and owners live with chronic uncertainty. Early recognition and aggressive treatment offer the best chance of survival with good welfare.

What You Can Do